Related Experiment Video
Updated: Jul 9, 2026
10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Gene expression in asthmatic airway smooth muscle
1Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0111, USA. prescott.woodruff@ucsf.edu
Proceedings of the American Thoracic Society
|December 21, 2007
Summary
Investigating airway smooth muscle in asthma reveals complex gene expression changes. Further research integrating multiple methods is needed to fully understand smooth muscle dysfunction in asthma.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Asthma Research
Background:
- Airway smooth muscle (ASM) abnormalities are key to asthma pathophysiology.
- ASM cell changes can involve number, size, phenotype, or function.
- Gene expression studies offer insight into in vivo ASM abnormalities in asthma.
Purpose of the Study:
- To identify abnormalities in airway smooth muscle cells in asthma using gene expression analysis.
- To explore the utility and limitations of gene expression profiling in asthma research.
Main Methods:
- Analysis of gene expression in freshly obtained asthmatic airway smooth muscle tissue.
- Gene expression microarrays on cultured ASM cells exposed to asthma mediators (e.g., IL-13).
Main Results:
- Conflicting results from in vivo studies on myosin light-chain kinase expression in asthmatic ASM.
- In vitro studies show IL-13 induces tenascin, H1 histamine receptor, and IL-13 receptor subunits in ASM.
- Significance of microarray findings for ASM function remains uncertain.
Conclusions:
- Gene expression studies in asthma are technically challenging and yield sometimes conflicting results.
- In vitro findings require validation for in vivo relevance to ASM function.
- Integrating gene expression data with other methodologies is crucial for comprehensive understanding of ASM in asthma.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...